Sandouk P, Serrie A, Scherrmann J M, Langlade A, Bourre J M
INSERM U.26, Laboratoire de Neurotoxicologie, Hôpital Fernand Widal, Paris, France.
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:166-71.
After intracerebroventricular administration of morphine in four cancer patients, cerebrospinal fluid (CSF) was analyzed by two morphine radioimmunoassays (RIA), liquid chromatography (LC) and radioreceptor assay (RRA) to evaluate the presence of morphine metabolites. Immunoreactive morphine-like substances were detected by differential RIA's. The maximum concentrations of these compounds were achieved 3 hours after drug administration. These concentrations, according to the specificity of the antiserum, represent a mixture of several metabolites in which only morphine 3-glucuronide(M 3-G) and morphine 6-glucuronide (M 6-G) were identified by LC, and M 6-G by LC-RRA. These results confirm that brain is able to metabolize morphine to inactive (M 3-G) or more potent (M 6-G) derivatives.
在对四名癌症患者进行脑室内注射吗啡后,通过两种吗啡放射免疫测定法(RIA)、液相色谱法(LC)和放射受体测定法(RRA)对脑脊液(CSF)进行分析,以评估吗啡代谢物的存在情况。通过差异RIA检测到免疫反应性吗啡样物质。这些化合物的最大浓度在给药后3小时达到。根据抗血清的特异性,这些浓度代表几种代谢物的混合物,其中通过LC仅鉴定出吗啡3-葡萄糖醛酸苷(M 3-G)和吗啡6-葡萄糖醛酸苷(M 6-G),通过LC-RRA鉴定出M 6-G。这些结果证实大脑能够将吗啡代谢为无活性的(M 3-G)或更强效的(M 6-G)衍生物。